Funding profile · Healthcare IT
Akute Health
A Y Combinator-backed EHR for cash-pay clinics with one disclosed dollar figure in the public record. No Form D has ever been filed under the company’s name.
Data as of September 25, 2026. Company-reported figures are labeled.
Rounds at a glance
| When | Round | Amount | Investors | Source |
|---|---|---|---|---|
| Feb 1, 2021 | Accelerator/Incubator | Not disclosed | Not named in this event | PitchBook |
| Jul 16, 2021 | Early Stage VC | Not disclosed | Not named in this event | PitchBook |
| Aug 31, 2021 | Accelerator/Incubator | $125,000 | Y Combinator | PitchBook |
| Undated | Investor list, not tied to a specific event | Not disclosed | Pareto Holdings, Right Side Capital Management, StartUp Health, The Finger Group | PitchBook |
What the filings show
Nothing, as far as the SEC is concerned. A full text search of SEC EDGAR for “Akute Health” returns zero results, and an EDGAR company search for “akute” filtered to Form D returns zero filings. That is unusual for a company that Y Combinator, PitchBook and Tracxn all agree has taken outside investment, and it means every dollar figure below comes from a third-party data aggregator rather than a regulatory filing.
PitchBook, which tracks private-company deals, lists three funding events for AkuteHealth in 2021: an Accelerator/Incubator deal on February 1, an Early Stage VC deal on July 16, and a second Accelerator/Incubator deal on August 31 tied to Y Combinator, the only one with a dollar amount attached, $125,000. Its investor table names five backers overall: Y Combinator, Pareto Holdings, Right Side Capital Management, StartUp Health and The Finger Group, without stating which of them participated in which event. Tracxn separately records a Seed round dated September 1, 2021, with a total funding figure of $125,000 and Y Combinator as the sole named investor, roughly consistent with PitchBook’s accelerator entry but silent on the other two 2021 events.
Reading the filings
- Only one number is real.Every aggregator that covers Akute converges on $125,000 as total disclosed funding, which is the standard size of a Y Combinator accelerator check, not a separate priced round.
- Three events, seven months, no other price.PitchBook’s February and July 2021 entries carry no dollar amount at all. That is consistent with a SAFE or note that a data vendor picked up from a source filing or investor disclosure without the amount, or with the vendor simply not obtaining it. Either way, the public record cannot say how much Akute has actually raised beyond the YC check.
- No SEC filing lines up with any of it.Companies that raise under Rule 506(b) of Regulation D are generally required to file a Form D, but small SAFE rounds handled directly between a startup and a handful of named angels or funds sometimes rely on Section 4(a)(2) instead, which carries no federal filing requirement. Zero EDGAR results for Akute Health is consistent with that path, though it cannot be confirmed without the company’s own cap table.
- The investor list is a pre-seed stack, not a growth round.Y Combinator, Right Side Capital Management and Pareto Holdings are all known for small, high-volume pre-seed checks; StartUp Health invests broadly across early digital health; The Finger Group reads as a family office. None of that points to a company that has closed an institutional priced round with a lead investor and a board seat.
- No later round has surfaced.No funding event after 2021 appears in PitchBook, Tracxn, Crunchbase’s indexed summary, or in web search results for the company as of September 2026, five years after the YC check.
Commercial signals
| Signal | Detail | Source type |
|---|---|---|
| Pricing | $300/mo Essentials (1 clinician, 100 patients) to $550/mo Premium (2 clinicians, 300 patients), plus a custom Developer tier with API access. | Company-stated |
| Platform reach | About 100 providers used Akute’s EMR as of the November 2024 Thea Health partnership announcement. | Company and partner |
| Named customer | Welcome Health, a direct primary care practice in Augusta, Georgia led by Dr. Rob Lamberts, appears in Akute’s own material; local business press independently confirms the practice and its founder but does not itself name Akute. | Independent, partial |
| Integration partners | Third parties Guava, Snapscale and Recupra each describe live integrations with Akute in their own LinkedIn posts, unprompted by Akute. | Independent |
| Headcount | 2 to 10 employees and 858 followers on LinkedIn; PitchBook and Tracxn both give 7 employees as of mid-2026. | Independent |
What to watch
- A first Form D, which would put a real number on anything raised since the 2021 YC check.
- Whether PitchBook or Tracxn update total funding past $125,000 as new information surfaces.
- Revenue or ARR disclosure tied to the roughly 100 providers reported in late 2024.
- A named lead investor for any future round, which none of the current backers appear to be.
The Akute Health story on Healthcare DiscoveryHealthcare Discovery
Related companies
Sources
- Public recordFull text search for “Akute Health,” zero results
- Public recordCompany search for “akute,” Form D filter, zero results
- IndependentAkuteHealth company profile, valuation, funding and investors
- IndependentAkuteHealth company profile, funding and founders
- IndependentAkute Health profile, jobs and funding
- IndependentAkute Health company page, updates and partner posts
- IndependentABD Expo Preview: Dr. Rob Lamberts, Welcome Health
- Company and partnerAkute Health and Thea Health Partner to Increase Access to Specialty Care for Primary Care Providers
- CompanyAkute Health homepage and pricing
Compiled from SEC and other public records and published reports as of September 25, 2026. Form D notices report offerings under Regulation D; amounts reflect the filing date. Healthcare Venture Capital Fund holds no position in Akute Health. This page is not an offer to sell or a recommendation to buy any security.